PORTOSPLENOMESENTERIC VENOUS THROMBOSIS

This adverse event was reported 61 times

These drugs are most commonly taken by patients reporting PORTOSPLENOMESENTERIC VENOUS THROMBOSIS:

# Drug Count
0 UPADACITINIB 8
1 METHOTREXATE SODIUM 7
2 ADALIMUMAB 4
3 ADALIMUMAB-AATY 4
4 ADALIMUMAB-ADAZ 4
5 ADALIMUMAB-FKJP 4
6 ATEZOLIZUMAB 4
7 DOCETAXEL 4
8 DOCETAXEL ANHYDROUS 4
9 METHOTREXATE 4
See all common drugs associated with PORTOSPLENOMESENTERIC VENOUS THROMBOSIS

PORTOSPLENOMESENTERIC VENOUS THROMBOSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FIBRINOGEN HUMAN 1 0.0043
1 AVATROMBOPAG MALEATE 2 0.0008
2 LEVONORGESTREL AND ETHINYL ESTRADIOL 1 0.0004
3 MEGESTROL ACETATE 1 0.0003
4 ROMIPLOSTIM 2 0.0001
5 VONOPRAZAN FUMARATE 1 0.0001
6 TESTOSTERONE CYPIONATE 1 0.0001
7 ATEZOLIZUMAB 4 0.0001
8 UPADACITINIB 8 0.0001
9 TRIFLURIDINE AND TIPIRACIL 1 0.0001
See all drugs enriched for association with PORTOSPLENOMESENTERIC VENOUS THROMBOSIS